23andMe Inc.

Powered by    favicon Technavio

23andMe Inc. | Data-Driven Analysis and Industry Review

Published: August 05, 2024

23andMe Inc. - Overview

23andMe Inc. is a prominent biotechnology company specializing in genetic testing and personal genomics. Founded in 2006, the company offers direct-to-consumer DNA testing services that provide insights into genetic health risks, ancestry, and traits. Its innovative approach to personal genomics has made it a leader in the consumer genetics market.

Market Position 23andMe holds a strong position in the genetic testing industry, characterized by:

  • Leadership in Direct-to-Consumer Testing: 23andMe is a pioneer in providing comprehensive genetic insights directly to consumers, distinguishing itself with user-friendly services and extensive genetic databases.
  • Partnerships and Collaborations: The company has formed significant partnerships with pharmaceutical companies, research institutions, and healthcare providers to advance genetic research and develop new therapeutics.
infographic

23andMe Inc. Market Portfolio | Comprehensive Overview

Browse Our Research Portfolio In 23andMe Inc. Markets

infographic

23andMe Inc. features in

Industries

Health Care

Health Care

Information Technology

Segments

Health Care Providers and Services

Health Care Providers and Services

Biotechnology

Software

Markets

Health Care Services

Health Care Services

Biotechnology

Application Software

About Technavio

With unparalleled market insights, our research is designed to elevate your business to new heights. Technavio stands at the forefront of market research with a global perspective. Our approach is grounded in four key principles: accessible reports, comprehensive industry analysis, a focus on innovative and emerging technologies, and competitive pricing. We are dedicated to empowering companies and executives to make informed, timely, and strategic decisions.